Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin added to pioglitazone in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study Article Proceedings Paper

cited authors

  • Pratley, Richard E.; Reusch, Jane E. -B.; Fleck, Penny R.; Wilson, Craig A.; Mekki, Qais; Alogliptin Study 009 Grp

authors

Publication Date

  • October 1, 2009

webpage

published in

category

keywords

  • Alogliptin
  • Dipeptidyl peptidase-4 inhibitor
  • Glycemic control
  • Thiazolidinedione
  • Type 2 diabetes

start page

  • 2361

end page

  • 2371

volume

  • 25

issue

  • 10